Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ARTIVION, INC.CRY · Entity 4767 | Director | August 25, 2021 | August 26, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ARTIVION, INC.
Report date August 25, 2021 · Filed August 26, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 121,768 |
Reported balance
After 2021-08-25 transaction · row 1
1 source rowRow 1 · 2021-08-25 · Sale · Disposed 5,667 · Balance 121,768 F1: Reflects weighted average price. Range of prices were between $25.625 to $25.69. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects weighted average price. Range of prices were between $25.625 to $25.69. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 25, 2021 Filed Aug 26, 2021 20:13 UTC | ARTIVION, INC. CRY · Entity 4767 | SaleCommon Stock | 5,667 | $25.63 | $145,265.61 |
DisclosureSEC source: 0000784199-21-000192 · certent-form4.xml · nonDerivative · entry 1 McCall Ronald D · CIK 0001016766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,768 F1 · price: Reflects weighted average price. Range of prices were between $25.625 to $25.69. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 01, 2021 Filed Jun 2, 2021 20:25 UTC | ARTIVION, INC. CRY · Entity 4767 | GrantCommon Stock | 4,423 | $29.39 | $129,991.97 |
DisclosureSEC source: 0000784199-21-000173 · certent-form4.xml · nonDerivative · entry 1 McCall Ronald D · CIK 0001016766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,435 F1 · shares: Represents shares of restricted stock that cliff vest on June 1, 2022, provided the status as a Director with CryoLife continues through such date. Read SEC document |
| May 25, 2021 Filed May 27, 2021 20:55 UTC | ARTIVION, INC. CRY · Entity 4767 | SaleCommon Stock | 5,783 | $29.55 | $170,888.23 |
DisclosureSEC source: 0000784199-21-000156 · certent-form4.xml · nonDerivative · entry 1 McCall Ronald D · CIK 0001016766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,012 F1 · price: Reflects weighted average price. Range of prices were between $29.44 to $29.77. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 14, 2020 Filed Dec 15, 2020 21:38 UTC | ARTIVION, INC. CRY · Entity 4767 | SaleCommon Stock | 4,638 | $21.79 | $101,068.51 |
DisclosureSEC source: 0000784199-20-000218 · certent-form4.xml · nonDerivative · entry 1 McCall Ronald D · CIK 0001016766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,795 F1 · price: Reflects weighted average price. Range of prices were between $21.55 to $21.96. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 01, 2020 Filed Jun 2, 2020 20:47 UTC | ARTIVION, INC. CRY · Entity 4767 | GrantCommon Stock | 5,667 | $22.94 | $130,000.98 |
DisclosureSEC source: 0000784199-20-000163 · certent-form4.xml · nonDerivative · entry 1 McCall Ronald D · CIK 0001016766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,433 F1 · shares: Represents shares of restricted stock that cliff vest on June 1, 2021, provided the status as a Director with CryoLife continues through such date. Read SEC document |
| May 05, 2020 Filed May 7, 2020 00:22 UTC | ARTIVION, INC. CRY · Entity 4767 | GrantCommon Stock | 1,620 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-20-000109 · certent-form4.xml · nonDerivative · entry 1 McCall Ronald D · CIK 0001016766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,485 F1 · shares: RSA Covid grant vests on May 4, 2021, provided the status as a Director with CryoLife continues through such date. Read SEC document |
| May 05, 2020 Filed May 7, 2020 21:14 UTC | ARTIVION, INC. CRY · Entity 4767 | SaleCommon Stock | 1,719 | $22.82 | $39,218.99 |
DisclosureSEC source: 0000784199-20-000115 · certent-form4.xml · nonDerivative · entry 1 McCall Ronald D · CIK 0001016766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,766 F1 · price: Reflects the price of $22.815 the shares were sold. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at this price Read SEC document |
| February 24, 2020 Filed Feb 25, 2020 21:38 UTC | ARTIVION, INC. CRY · Entity 4767 | SaleCommon Stock | 4,734 | $26.05 | $123,339.64 |
DisclosureSEC source: 0000784199-20-000051 · certent-form4.xml · nonDerivative · entry 1 McCall Ronald D · CIK 0001016766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,865 F1 · price: Reflects weighted average price. Range of prices were between $24.05 to $26.08. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 19, 2019 Filed Nov 19, 2019 21:43 UTC | ARTIVION, INC. CRY · Entity 4767 | SaleCommon Stock | 4,000 | $24.64 | $98,564.80 |
DisclosureSEC source: 0000784199-19-000164 · certent-form4.xml · nonDerivative · entry 1 McCall Ronald D · CIK 0001016766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,599 F1 · price: Reflects weighted average price. Range of prices were between $24.5 to $24.67. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 24, 2019 Filed May 29, 2019 20:16 UTC | ARTIVION, INC. CRY · Entity 4767 | SaleCommon Stock | 1,563 | $28.47 | $44,498.61 |
DisclosureSEC source: 0000784199-19-000126 · certent-form4.xml · nonDerivative · entry 1 McCall Ronald D · CIK 0001016766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,599 F1 · price: Reflects weighted average price. Range of prices were between $28.40 to $28.57. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 23, 2019 Filed May 24, 2019 20:18 UTC | ARTIVION, INC. CRY · Entity 4767 | SaleCommon Stock | 1,000 | $28.00 | $28,000.00 |
DisclosureSEC source: 0000784199-19-000124 · certent-form4.xml · nonDerivative · entry 2 McCall Ronald D · CIK 0001016766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,162 F2 · price: Reflects the price of $28 the shares were sold. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at this price Read SEC document |
| May 22, 2019 Filed May 24, 2019 20:18 UTC | ARTIVION, INC. CRY · Entity 4767 | SaleCommon Stock | 2,700 | $29.02 | $78,345.90 |
DisclosureSEC source: 0000784199-19-000124 · certent-form4.xml · nonDerivative · entry 1 McCall Ronald D · CIK 0001016766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,162 F1 · price: Reflects weighted average price. Range of prices were between $29.00 to $29.06. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 16, 2019 Filed May 17, 2019 20:25 UTC | ARTIVION, INC. CRY · Entity 4767 | GrantCommon Stock | 4,163 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-19-000118 · certent-form4.xml · nonDerivative · entry 1 McCall Ronald D · CIK 0001016766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,862 F1 · shares: Represents shares of restricted stock that cliff vest on May 16, 2020, provided the status as a Director with CryoLife continues through such date. Read SEC document |
| February 21, 2019 Filed Feb 26, 2019 00:52 UTC | ARTIVION, INC. CRY · Entity 4767 | SaleCommon Stock | 6,200 | $29.26 | $181,389.68 |
DisclosureSEC source: 0000784199-19-000026 · certent-form4.xml · nonDerivative · entry 1 McCall Ronald D · CIK 0001016766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,699 F1 · price: Reflects weighted average price. Range of prices were between $29.13 to $25.28. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 09, 2018 Filed Aug 13, 2018 20:39 UTC | ARTIVION, INC. CRY · Entity 4767 | SaleCommon Stock | 2,750 | $32.69 | $89,900.25 |
DisclosureSEC source: 0000784199-18-000167 · certent-form4.xml · nonDerivative · entry 1 McCall Ronald D · CIK 0001016766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,899 F1 · price: Reflects weighted average price. Range of prices were between $32.55 to $33. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 23, 2018 Filed May 25, 2018 21:19 UTC | ARTIVION, INC. CRY · Entity 4767 | GrantCommon Stock | 4,638 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-18-000115 · certent-form4.xml · nonDerivative · entry 1 McCall Ronald D · CIK 0001016766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,649 F1 · shares: Represents shares of restricted stock that cliff vest on May 23, 2019, provided the status as a Director with CryoLife continues through such date. Read SEC document |
| May 10, 2018 Filed May 11, 2018 21:23 UTC | ARTIVION, INC. CRY · Entity 4767 | SaleCommon Stock | 2,000 | $25.39 | $50,781.80 |
DisclosureSEC source: 0000784199-18-000097 · certent-form4.xml · nonDerivative · entry 2 McCall Ronald D · CIK 0001016766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,271 F2 · price: Reflects weighted average price. Range of prices were between $25.30 to $25.50. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 09, 2018 Filed May 11, 2018 21:23 UTC | ARTIVION, INC. CRY · Entity 4767 | SaleCommon Stock | 2,240 | $25.67 | $57,494.08 |
DisclosureSEC source: 0000784199-18-000097 · certent-form4.xml · nonDerivative · entry 1 McCall Ronald D · CIK 0001016766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,271 F1 · price: Reflects weighted average price. Range of prices were between $25.60 to $25.75. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 08, 2018 Filed May 15, 2018 21:30 UTC | ARTIVION, INC. CRY · Entity 4767 | SaleCommon Stock | 260 | $25.95 | $6,747.00 |
DisclosureSEC source: 0000784199-18-000099 · certent-form4.xml · nonDerivative · entry 1 McCall Ronald D · CIK 0001016766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,011 F1 · price: Reflects the price of $25.95 the shares were sold. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at this price. Read SEC document |
| March 08, 2018 Filed Mar 9, 2018 21:51 UTC | ARTIVION, INC. CRY · Entity 4767 | SaleCommon Stock | 5,000 | $21.09 | $105,447.50 |
DisclosureSEC source: 0000784199-18-000059 · certent-form4.xml · nonDerivative · entry 1 McCall Ronald D · CIK 0001016766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,511 F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on November 14, 2017 F2 · price: Reflects weighted average price. Range of prices were between $21 to $21.25. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 22, 2017 Filed May 24, 2017 13:21 UTC | ARTIVION, INC. CRY · Entity 4767 | Disposition to issuerCommon Stock | 7,000 | $18.28 | $127,938.30 |
DisclosureSEC source: 0000784199-17-000063 · certent-form4.xml · nonDerivative · entry 1 McCall Ronald D · CIK 0001016766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,511 F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 12, 2016. F2 · price: Reflects weighted average price. Range of prices were between $18.20 to $18.40. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 17, 2017 Filed May 18, 2017 20:39 UTC | ARTIVION, INC. CRY · Entity 4767 | GrantCommon Stock | 5,263 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-17-000055 · certent-form4.xml · nonDerivative · entry 1 McCall Ronald D · CIK 0001016766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,511 F1 · shares: Represents shares of restricted stock that vest on the first anniversary of the grant date if the reporting person remains a member of the Company's board of directors, subject to earlier vesting upon certain events including death, disability and retirement from the board after serving out his full term because the director is not standing for re-election at the end of the term. Read SEC document |
| September 15, 2016 Filed Sep 16, 2016 20:31 UTC | ARTIVION, INC. CRY · Entity 4767 | Disposition to issuerCommon Stock | 3,000 | $17.54 | $52,630.80 |
DisclosureSEC source: 0000784199-16-000301 · certent-form4.xml · nonDerivative · entry 1 McCall Ronald D · CIK 0001016766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,248 F1 · price: Reflects the weighted price of $17.5436 the shares were sold. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at this price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.